Mesalamine Intolerance in Three Children with Crohn's Disease
dc.contributor.author | Kirsaclioglu, Ceyda Tuna | |
dc.contributor.author | Kuloglu, Zarife | |
dc.contributor.author | Ustundag, Gonca | |
dc.contributor.author | Kansu, Aydan | |
dc.contributor.author | Ince, Erdal | |
dc.contributor.author | Ensari, Arzu | |
dc.contributor.author | Girgin, Nurten | |
dc.contributor.department | TIP FAKÜLTESİ | tr_TR |
dc.date.accessioned | 2019-07-01T12:04:01Z | |
dc.date.available | 2019-07-01T12:04:01Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Objective: To present the mesalamine-induced acute exacerbation of symptoms and inflammatory markers in children with Crohn's disease (CD). Clinical Presentation and Intervention: Three children who presented with CD had acute exacerbation of colitis symptoms or elevated inflammatory markers when mesalamine was added to treatment while tapering/ceasing steroid treatment. While on steroid treatment, the patients maintained clinical and laboratory remission, but with the initiation of mesalamine treatment, they had abdominal pain and bloody mucoid diarrhoea and/or elevation of white blood cell count, C-reactive protein level and erythrocyte sedimentation rate. Bacterial pathogens were excluded from the urine, throat and blood cultures, parasites with stool examination, viral pathogens with serology. Within 3-7 days after the mesalamine treatment had been stopped, the patients showed improvement of colitis symptoms and normalisation of white blood cell count, C-reactive protein level and erythrocyte sedimentation rate. Conclusion: In this study mesalamine mimicked CD relapse in children with CD while tapering or after stopping steroid treatment. Awareness of this side effect of mesalamine could prevent a misdiagnosis of steroid dependency. (C) 2015 S. Karger AG, Basel | tr_TR |
dc.description.index | Wos | |
dc.description.index | wos | |
dc.identifier.endpage | 03 | tr_TR |
dc.identifier.other | 10.1159/000442946 | |
dc.identifier.startpage | 01 | tr_TR |
dc.identifier.uri | http://hdl.handle.net/20.500.12575/67043 | |
dc.language.iso | en | tr_TR |
dc.relation.index | WOS | tr_TR |
dc.relation.journal | MEDICAL PRINCIPLES AND PRACTICE | tr_TR |
dc.subject | Children | tr_TR |
dc.subject | Crohn's disease | tr_TR |
dc.subject | Mesalamine | tr_TR |
dc.title | Mesalamine Intolerance in Three Children with Crohn's Disease | tr_TR |
dc.type | Article | tr_TR |